Pro-Implant Foundation Report issue

Foundation Phase 4

Organization Overview

First Clinical Trial
2018
NCT03260010
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Pro-Implant Foundation